PFE: Pfizer, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 212,067.48
Enterprise Value ($M) 251,508.69
Book Value ($M) 58,806.00
Book Value / Share 10.63
Price / Book 3.62
NCAV ($M) -50,973.00
NCAV / Share -9.22
Price / NCAV -4.18

Profitability (mra)
Return on Invested Capital (ROIC) 0.11
Return on Assets (ROA) 0.07
Return on Equity (ROE) 0.16

Liquidity (mrq)
Quick Ratio 1.27
Current Ratio 1.54

Balance Sheet (mrq) ($M)
Current Assets 45,290.00
Assets 155,000.00
Liabilities 96,263.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income n/a
Net Income 11,188.00
Earnings Per Share Diluted 1.87
Earnings Per Share Basic 1.90

Cash Flow Statement (mra) ($M)
Cash From Operations 15,827.00
Cash from Investing 4,525.00
Cash from Financing 4,525.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
2019-02-14 13G State Street Corp 5.10 -5.34
2019-02-11 13G/A Vanguard Group Inc 7.81 4.29
2019-02-06 13G/A BlackRock Inc. 8.00 2.22

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2019-11-07 10-Q PFE / Pfizer, Inc. 10-Q – Quarterly Report – 10-Q
2019-08-08 10-Q PFE / Pfizer, Inc. 10-Q – Quarterly Report – 10-Q
2019-05-09 10-Q PFE / Pfizer, Inc. 10-Q Quarterly Report 10-Q
2019-02-28 10-K PFE / Pfizer, Inc. FORM 10-K (Annual Report)

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2019-12-09 993,435 14,971,200 6.64
2019-12-06 968,277 12,213,300 7.93
2019-12-05 1,260,614 12,427,300 10.14
2019-12-04 860,400 13,759,200 6.25

(click for more detail)

Similar Companies
MNK – Maillinckrodt plc. MRK – Merck & Co., Inc.
PBH – Prestige Brands Holdings, Inc. PRGO – Perrigo Company plc
USNA – USANA Health Sciences, Inc.


Financial data and stock pages provided by
Fintel.io